Skip to main content
. 2017 May 19;12(5):e0178091. doi: 10.1371/journal.pone.0178091

Fig 2. Delayed treatment and redundant testing.

Fig 2

At both sites, the use of the Scr+uNGAL would be expected to reduce the number of patients with delayed diagnoses and treatment. For a hypothetical cohort of 10,000 patients, the Scr+uNGAL strategy would lead to 1,578 fewer patients with diagnosis and treatment delays at the NYP-Allen, and 1,973 fewer patients with such delays at SIUH. However, Scr+uNGAL could lead to redundant testing at both centers. …